Status:
COMPLETED
Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
Lead Sponsor:
Northwestern University
Conditions:
Heart Failure
Cardiovascular Risk Factor
Eligibility:
All Genders
30-79 years
Phase:
NA
Brief Summary
The purpose of this study is to gather information to develop a heart failure screening and prevention program.
Detailed Description
All participants will undergo phlebotomy for specimen collection (BNP, hs-cTn, BMP and lipid testing, biorepository storage) and baseline echocardiography. All participants will additionally be admini...
Eligibility Criteria
Inclusion
- 10-year risk of heart failure \>5% based on the PCP-HF equations
- At least one primary care visit in the last 12 months
- At least one additional primary care visit in the last 5 years
- Had cholesterol and glucose checked within the past 5 years
Exclusion
- History of cardiovascular disease
- Signs and symptoms of heart failure
- Estimated glomerular filtration rate \<45 mL/min/1.73m\^2
- Stage 3 or 4 cancer
- Pregnancy
Key Trial Info
Start Date :
March 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04684264
Start Date
March 3 2021
End Date
February 1 2024
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Department of Preventive Medicine
Chicago, Illinois, United States, 60611